In HCC, METTL3 regulates the stability of SLC7A11 mRNA in an m6A/IGF2BP2-de- pendent manner, which can modulate the sensitivity of hepatocellular carcinoma to radiotherapy. Here, IGF2BP2 is linked to hepatocellular carcinoma.